UroGen Pharma URGN
NASDAQ URGN
$25.32 -1.01 (-3.84%)
At close: Nov 10, 2026 · 4:00 PM EST

UroGen Pharma (URGN) Preferred Shares (2016)

Updated

UroGen Pharma (URGN) recorded Preferred Shares of $13,000 in Q4 2016.

Analysis

UroGen Pharma (URGN) Preferred Shares (2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 UroGen Pharma 1.24 Bn 782.15 Mn 81.50 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 13,000.00
API Access

UroGen Pharma Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=URGN&period=max&api_key=YOUR_API_KEY